Natco Pharma Ltd Company Profile
✉ Email this page to a colleague
What is the competitive landscape for NATCO PHARMA LTD, and what generic and branded alternatives to NATCO PHARMA LTD drugs are available?
NATCO PHARMA LTD has seventeen approved drugs.
There are two tentative approvals on NATCO PHARMA LTD drugs.
Summary for Natco Pharma Ltd
US Patents: | 0 |
Tradenames: | 15 |
Ingredients: | 15 |
NDAs: | 17 |
Drug Master File Entries: | 43 |
Patent Litigation for Natco Pharma Ltd: | See patent lawsuits for Natco Pharma Ltd |
Drugs and US Patents for Natco Pharma Ltd
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Natco Pharma Ltd | ARMODAFINIL | armodafinil | TABLET;ORAL | 202768-004 | Sep 28, 2017 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Natco Pharma Ltd | RIZATRIPTAN BENZOATE | rizatriptan benzoate | TABLET;ORAL | 200482-001 | Dec 31, 2012 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Natco Pharma Ltd | ERLOTINIB HYDROCHLORIDE | erlotinib hydrochloride | TABLET;ORAL | 208488-003 | Nov 5, 2019 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.